Delayed Sputum Culture Conversion in Tuberculosis–Human Immunodeficiency Virus–Coinfected Patients With Low Isoniazid and Rifampicin Concentrations Article Swipe
Related Concepts
Medicine
Isoniazid
Sputum
Rifampicin
Tuberculosis
Sputum culture
Internal medicine
Culture conversion
Hazard ratio
Mycobacterium tuberculosis
Quartile
Confidence interval
Pathology
Christine Sekaggya‐Wiltshire
,
Amrei von Braun
,
Mohammed Lamorde
,
Bruno Ledergerber
,
Allan Buzibye
,
Lars Henning
,
Joseph Musaazi
,
Ursula Gutteck
,
Paolo Denti
,
Miné de Kock
,
Alexander Jetter
,
Pauline Byakika‐Kibwika
,
Nadia Eberhard
,
Joshua Matovu
,
Moses Joloba
,
Daniel J. Müller
,
Yukari C. Manabe
,
Moses R. Kamya
,
Natascia Corti
,
Andrew Kambugu
,
Barbara Castelnuovo
,
Jan Fehr
·
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1093/cid/ciy179
· OA: W2791208418
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1093/cid/ciy179
· OA: W2791208418
Although low antituberculosis drug concentrations did not translate to a high proportion of patients with treatment failure, the association between low concentrations of rifampicin and isoniazid and delayed culture conversion may have implications for tuberculosis transmission. Clinical Trials Registration: NCT01782950.
Related Topics
Finding more related topics…